Biofunctionalized Nanoconjugates: Design, Production, and Characterization

Many diagnostic and nanomedicine projects fail to progress beyond the prototype stage because the recognition element and the nanostructured carrier are developed separately. In practice, antibody generation, hapten design, and immunoassay development require strong expertise in antigen selection and bioconjugation, while colloidal systems intended for diagnostics, drug delivery, or theranostics must be optimized for size, surface charge, stability, formulation robustness, and reproducibility. This gap becomes even more critical when the final product is an antibody-functionalized nanoprobe, a liposomal or micellar assay reagent, or a bioconjugate intended for point-of-care use. 

Description

This combined service offers an integrated workflow that connects the production of custom antibodies and immunoreagents (U2) with the physicochemical characterization of nanostructured liquids, dispersions, and nanoassemblies (U12). U2 contributes the design of haptens and peptides, antibody generation and purification, immunoassay development, and bioconjugation expertise. U12 adds advanced characterization of colloidal systems, including DLS/SLS, zeta potential, colloidal stability, phase behavior, surface/interfacial tension, viscosity, microscopy, and SEM. Together, both units provide a seamless route to develop, optimize, and validate antibody-based nanoprobes, nanodiagnostics, and nanoformulations with higher robustness and translational potential.

More info: https://www.nanbiosis.es/biofunctionalized-nanoconjugates-design-production-and-characterization/